Discordance in Biomarker Expression in Breast Cancer After Metastasis: Single Center Experience in India

PURPOSE: Biomarker—estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu) —discordance plays an essential role in the management and prognosis of patients with metastatic breast cancer. Rates of discordance have been previously reported around 12%...

Full description

Bibliographic Details
Main Authors: Ajay Gogia, S. V. Suryanarayana Deo, Dayanand Sharma, Rakesh K. Phulia, Sanjay Thulkar, Prabhat S. Malik, Sandeep Mathur
Format: Article
Language:English
Published: American Society of Clinical Oncology 2019-04-01
Series:Journal of Global Oncology
Online Access:http://ascopubs.org/doi/10.1200/JGO.18.00184

Similar Items